Posted on 10/26/20
Bayer Acquires Asklepios BioPharmaceutical
Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in the research, development a
Posted on 10/26/20
U.Va. Researcher: COVID-19 Drug Appears To Not Work Well For Diabetics
A University of Virginia physicist researching a drug that can save severely ill COVID-19 patients’ lives has discovered that it may not work well on diabetics, . . .
Posted on 10/26/20
Mavenir Makes Play For $300 Million U.S. IPO
SummaryMavenir has filed proposed terms for a $300 million IPO of its Class A common stock.The firm provides software for wireless service providers worldwide.MVNR has produced . . .
Posted on 10/26/20
NantKwest COVID-19 Candidate, And Other News: The Good, Bad And Ugly Of Biopharma
SummaryNantKwest announces initiation of second generation COVID-19 vaccine candidate.Protagonist Therapeutics receives orphan drug status for PTG-300.Genmab reports positive data from Phase 2 CASSIOPEIA study.Looking for more . . .
Posted on 10/26/20
Better Coronavirus Stock: Moderna or Novavax?
Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) have been taking turns at center stage with their coronavirus vaccine programs. Moderna grabbed investors' attention in March when it became . . .
Posted on 10/26/20
Pfizer Stock: Headed to $42?
Pfizer (NYSE:PFE) has had its ups and downs as a company, but one prognosticator thinks it's got more of the former than the latter coming up. . . .
Posted on 10/26/20
Vertex: Recent Clinical Setback Underscores The Need To Expand The Pipeline
SummaryThe market overreacted last week to the early-stage clinical program setback, the discontinuation of VX-814 due to toxicity problems.However, last week's reaction underscores the need to . . .
Posted on 10/26/20
How Much Is Moderna Really Worth?
The world's desperate need for vaccines and treatments to fight the COVID-19 pandemic has thrust a few companies into the limelight, including Moderna. The Massachusetts-based biotech, . . .
Posted on 10/26/20
Better Coronavirus Stock: Moderna or Novavax?
Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) have been taking turns at center stage with their coronavirus vaccine programs. Moderna grabbed investors' attention in March when it became . . .
Posted on 10/26/20
Why Is Everyone Talking About Moderna Stock?
Right now, nearly everyone in the healthcare investment world -- and perhaps in the general investment world -- is talking about Moderna (NASDAQ:MRNA). The biotech, which . . .
Posted on 10/26/20
Battle Plan for Baltimore’s Disproportionately High Childhood Asthma Rates
Children in Baltimore suffer from asthma at a rate more than double the national average, but the city’s response to this long-recognized disparity has continued to . . .
Posted on 10/23/20
Gracie Square Hospital Raises Awareness during October: National Depression and Mental Health Screening Month
Depression is one of the most common mental health disorders, but the pandemic has increased the number of adults struggling with symptoms. In fact, data from a . . .
Posted on 10/23/20
Eucrates Biomedical Acquisition Prices of $100 Million IPO
Eucrates Biomedical Acquisition Corp., a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar . . .
Posted on 10/23/20
Milestone Pharmaceuticals Prices of a Public Offering of $45 Million of Common Shares
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the . . .
Posted on 10/23/20
ProPhase Labs to Acquire CLIA
ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to acquire a Clinical Laboratory Improvement Amendments
Posted on 10/23/20
Sirnaomics Seals $105 Million Series D Financing
Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed its USD$105 million Series D financing.
Posted on 10/23/20
Here's Why Quest Diagnostics Made Investors Happy With Its Q3 Results
Quest Diagnostics (NYSE:DGX) has taken investors on a roller-coaster ride so far in 2020. But the ride has been a fun one over the last couple . . .
Posted on 10/23/20
Is Regeneron a Buy Before Nov. 3?
Regeneron Pharmaceuticals (NASDAQ:REGN) made headlines recently after President Trump, diagnosed with COVID-19 earlier this month, took the biotech's investigational treatment. Trump, who also took other experimental . . .
Posted on 10/23/20
Black Diamond Therapeutics: One To Watch In Precision Oncology Space
SummaryBlack Diamond is an innovative cancer drug-developer using genetic sequencing to identify families of allosteric mutations, and developing drug molecules to inhibit their proliferation.The company raised . . .
Posted on 10/23/20
Moderna Completes Enrollment in Its Late-Stage Coronavirus Vaccine Trial
Moderna (NASDAQ:MRNA) announced today that it has completed enrollment in the 30,000-participant study of mRNA-1273, the company's vaccine designed to protect against the novel coronavirus that . . .
Posted on 10/23/20
Foghorn Therapeutics Prices of IPO
CAMBRIDGE, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines . . .
Posted on 10/23/20
Plus Therapeutics Reports Third Quarter 2020 Financial Results
AUSTIN, Texas, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), today announced financial results for the third quarter ended September 30, 2020, and . . .
Posted on 10/23/20
Coronavirus Weekly Recap (Oct. 15 – 22): Average Positive Test Rate Above 3% for Nine Straight Days
Maryland’s seven-day average rate of positive coronavirus tests has been higher than 3 percent for nine consecutive days, state data show.After the average rose to 3.09 . . .
Posted on 10/22/20
West Announces Third-Quarter 2020 Results
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.Third-Quarter 2020 Summary (comparisons to prior-year . . .
Posted on 10/22/20
Quest Diagnostics Reports Third Quarter 2020 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2020."Quest had . . .

